Stockscreener 앱 받기
550.97
2.62%
-18.00
전일 마감가:
$568.97
열려 있는:
$557.48
하루 거래량:
14.04M
Relative Volume:
0.80
시가총액:
$1.40T
수익:
$214.96B
순이익/손실:
$70.59B
주가수익비율:
20.03
EPS:
27.5066
순현금흐름:
$48.25B
1주 성능:
-7.52%
1개월 성능:
-14.23%
6개월 성능:
-13.86%
1년 성능:
-27.80%
1일 변동 폭
$545.47
$560.66
1주일 범위
$545.47
$604.50
52주 변동 폭
$520.26
$790.80
메타 플랫폼스 Stock (META) Company Profile
명칭
Meta Platforms Inc
전화
650-543-4800
주소
1 META WAY, MENLO PARK
Compare META vs GOOGL, GOOG, SPOT, DASH
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
META
Meta Platforms Inc
|
550.68 | 1.50T | 214.96B | 70.59B | 48.25B | 27.51 |
GOOGL
Alphabet Inc
|
343.67 | 4.23T | 446.32B | 244.21B | 53.27B | 19.91 |
GOOG
Alphabet Inc
|
341.29 | 4.20T | 446.32B | 244.21B | 53.27B | 19.91 |
SPOT
Spotify Technology Sa
|
522.64 | 105.43B | 20.32B | 3.16B | 3.82B | 12.55 |
DASH
Doordash Inc
|
221.16 | 94.03B | 14.72B | 923.00M | 1.75B | 2.0994 |
메타 플랫폼스 Stock (META) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-07-30 | 재확인 | Monness Crespi & Hardt | Buy |
| 2026-07-16 | 재개 | Wedbush | Neutral |
| 2026-07-10 | 재확인 | Citizens | Mkt Outperform |
| 2026-07-07 | 업그레이드 | Erste Group | Hold → Buy |
| 2026-06-02 | 업그레이드 | Arete | Neutral → Buy |
| 2026-05-20 | 재확인 | Wells Fargo | Overweight |
| 2026-05-05 | 재확인 | Mizuho | Outperform |
| 2026-04-30 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2026-04-10 | 재확인 | Wolfe Research | Outperform |
| 2026-04-09 | 재확인 | Rosenblatt | Buy |
| 2026-04-02 | 다운그레이드 | Erste Group | Buy → Hold |
| 2026-03-30 | 재확인 | Morgan Stanley | Overweight |
| 2026-03-05 | 다운그레이드 | Arete | Buy → Neutral |
| 2026-03-05 | 업그레이드 | Erste Group | Hold → Buy |
| 2026-02-23 | 재확인 | Wells Fargo | Overweight |
| 2026-01-29 | 재확인 | Canaccord Genuity | Buy |
| 2026-01-29 | 재확인 | Cantor Fitzgerald | Overweight |
| 2026-01-29 | 재확인 | Deutsche Bank | Buy |
| 2026-01-29 | 재확인 | Evercore ISI | Outperform |
| 2026-01-29 | 재확인 | Guggenheim | Buy |
| 2026-01-29 | 재확인 | JP Morgan | Overweight |
| 2026-01-29 | 재확인 | Jefferies | Buy |
| 2026-01-29 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2026-01-29 | 재확인 | Mizuho | Outperform |
| 2026-01-29 | 재확인 | Monness Crespi & Hardt | Buy |
| 2026-01-29 | 재확인 | Morgan Stanley | Overweight |
| 2026-01-29 | 재확인 | Piper Sandler | Overweight |
| 2026-01-29 | 재확인 | Pivotal Research Group | Buy |
| 2026-01-29 | 재확인 | Robert W. Baird | Outperform |
| 2026-01-29 | 재확인 | Roth Capital | Buy |
| 2026-01-29 | 재확인 | Stifel | Buy |
| 2026-01-29 | 재확인 | UBS | Buy |
| 2026-01-29 | 재확인 | Wedbush | Outperform |
| 2026-01-29 | 재확인 | Wells Fargo | Overweight |
| 2026-01-29 | 재확인 | Wolfe Research | Outperform |
| 2026-01-26 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2026-01-26 | 재확인 | Raymond James | Strong Buy |
| 2026-01-26 | 업그레이드 | Rothschild & Co Redburn | Neutral → Buy |
| 2026-01-23 | 재확인 | Stifel | Buy |
| 2026-01-13 | 재확인 | TD Cowen | Buy |
| 2026-01-12 | 재확인 | Wells Fargo | Overweight |
| 2026-01-08 | 재확인 | Cantor Fitzgerald | Overweight |
| 2026-01-08 | 재확인 | Guggenheim | Buy |
| 2025-12-04 | 업그레이드 | Arete | Neutral → Buy |
| 2025-11-24 | 개시 | BNP Paribas Exane | Outperform |
| 2025-11-10 | 다운그레이드 | Erste Group | Buy → Hold |
| 2025-10-30 | 재확인 | Barclays | Overweight |
| 2025-10-30 | 재확인 | Bernstein | Outperform |
| 2025-10-30 | 재확인 | BofA Securities | Buy |
| 2025-10-30 | 재확인 | Citigroup | Buy |
| 2025-10-30 | 재확인 | JP Morgan | Overweight |
| 2025-10-30 | 재확인 | Jefferies | Buy |
| 2025-10-30 | 재확인 | Mizuho | Outperform |
| 2025-10-30 | 재확인 | Monness Crespi & Hardt | Buy |
| 2025-10-30 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-10-30 | 재확인 | Piper Sandler | Overweight |
| 2025-10-30 | 재확인 | Stifel | Buy |
| 2025-10-30 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2025-10-20 | 재확인 | Oppenheimer | Outperform |
| 2025-10-07 | 재확인 | Wells Fargo | Overweight |
| 2025-09-30 | 개시 | Mizuho | Outperform |
| 2025-07-31 | 재확인 | BMO Capital Markets | Market Perform |
| 2025-07-31 | 재확인 | Bernstein | Outperform |
| 2025-07-31 | 재확인 | BofA Securities | Buy |
| 2025-07-31 | 재확인 | Citigroup | Buy |
| 2025-07-31 | 재확인 | Citizens JMP | Mkt Outperform |
| 2025-07-31 | 재확인 | JP Morgan | Overweight |
| 2025-07-31 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2025-07-31 | 재확인 | Monness Crespi & Hardt | Buy |
| 2025-07-31 | 재확인 | Morgan Stanley | Overweight |
| 2025-07-31 | 재확인 | Oppenheimer | Outperform |
| 2025-07-31 | 재확인 | Pivotal Research Group | Buy |
| 2025-07-31 | 재확인 | TD Cowen | Buy |
| 2025-07-31 | 재확인 | UBS | Buy |
| 2025-07-31 | 재확인 | Wedbush | Outperform |
| 2025-07-31 | 재확인 | Wells Fargo | Overweight |
| 2025-07-28 | 재확인 | Guggenheim | Buy |
| 2025-07-16 | 재확인 | Canaccord Genuity | Buy |
| 2025-07-03 | 업그레이드 | Needham | Underperform → Hold |
| 2025-06-26 | 재확인 | UBS | Buy |
| 2025-06-24 | 재확인 | Citigroup | Buy |
| 2025-05-01 | 재확인 | BofA Securities | Buy |
| 2025-05-01 | 재확인 | Citigroup | Buy |
| 2025-05-01 | 재확인 | Evercore ISI | Outperform |
| 2025-05-01 | 재확인 | Goldman | Buy |
| 2025-05-01 | 재확인 | Guggenheim | Buy |
| 2025-05-01 | 재확인 | JP Morgan | Overweight |
| 2025-05-01 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2025-05-01 | 재확인 | MoffettNathanson | Buy |
| 2025-05-01 | 재확인 | Monness Crespi & Hardt | Buy |
| 2025-05-01 | 재확인 | Morgan Stanley | Overweight |
| 2025-05-01 | 재확인 | Oppenheimer | Outperform |
| 2025-05-01 | 재확인 | Piper Sandler | Overweight |
| 2025-05-01 | 재확인 | Pivotal Research Group | Buy |
| 2025-05-01 | 재확인 | Raymond James | Strong Buy |
| 2025-05-01 | 재확인 | Rosenblatt | Buy |
| 2025-05-01 | 재확인 | Roth Capital | Buy |
| 2025-05-01 | 재확인 | Stifel | Buy |
| 2025-05-01 | 재확인 | Truist | Buy |
| 2025-05-01 | 재확인 | UBS | Buy |
| 2025-05-01 | 재확인 | Wedbush | Outperform |
| 2025-04-14 | 재확인 | Citigroup | Buy |
| 2025-04-10 | 재확인 | Piper Sandler | Overweight |
| 2025-01-30 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2025-01-23 | 재확인 | BofA Securities | Buy |
| 2025-01-22 | 재확인 | Cantor Fitzgerald | Overweight |
| 2025-01-06 | 재확인 | Jefferies | Buy |
| 2025-01-03 | 재확인 | Wolfe Research | Outperform |
| 2024-10-31 | 재확인 | Monness Crespi & Hardt | Buy |
| 2024-10-31 | 재확인 | Pivotal Research Group | Buy |
| 2024-10-11 | 개시 | Scotiabank | Sector Perform |
| 2024-10-09 | 재확인 | Cantor Fitzgerald | Overweight |
| 2024-10-01 | 개시 | Pivotal Research Group | Buy |
| 2024-09-30 | 재확인 | Monness Crespi & Hardt | Buy |
| 2024-09-10 | 개시 | DA Davidson | Buy |
| 2024-09-05 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-08-01 | 재확인 | BofA Securities | Buy |
| 2024-07-19 | 재확인 | Oppenheimer | Outperform |
| 2024-07-16 | 개시 | Wolfe Research | Outperform |
| 2024-07-10 | 재확인 | TD Cowen | Buy |
| 2024-07-08 | 재확인 | Wells Fargo | Overweight |
| 2024-07-01 | 재확인 | Raymond James | Strong Buy |
| 2024-06-12 | 재확인 | BMO Capital Markets | Market Perform |
| 2024-05-02 | 개시 | Exane BNP Paribas | Underperform |
| 2024-04-25 | 재확인 | Oppenheimer | Outperform |
| 2024-04-15 | 재확인 | Citigroup | Buy |
| 2024-04-11 | 재확인 | Piper Sandler | Overweight |
| 2024-04-08 | 재확인 | Oppenheimer | Outperform |
| 2024-04-04 | 재확인 | Jefferies | Buy |
| 2024-02-02 | 재확인 | Guggenheim | Buy |
| 2024-02-02 | 재확인 | JMP Securities | Mkt Outperform |
| 2024-02-02 | 재확인 | JP Morgan | Overweight |
| 2024-02-02 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2024-02-02 | 재확인 | Mizuho | Buy |
| 2024-02-02 | 재확인 | Monness Crespi & Hardt | Buy |
| 2024-02-02 | 재확인 | Morgan Stanley | Overweight |
| 2024-02-02 | 재확인 | Oppenheimer | Outperform |
| 2024-02-02 | 재확인 | Piper Sandler | Overweight |
| 2024-02-02 | 재확인 | ROTH MKM | Buy |
| 2024-02-02 | 재확인 | Raymond James | Strong Buy |
| 2024-02-02 | 재확인 | Robert W. Baird | Outperform |
| 2024-02-02 | 재확인 | Seaport Research Partners | Buy |
| 2024-02-02 | 재확인 | Stifel | Buy |
| 2024-02-02 | 재확인 | Susquehanna | Positive |
| 2024-02-02 | 재확인 | TD Cowen | Outperform |
| 2024-02-02 | 재확인 | UBS | Buy |
| 2024-02-02 | 재확인 | Wedbush | Outperform |
| 2024-02-02 | 재확인 | Wells Fargo | Overweight |
| 2024-02-02 | 재확인 | Wolfe Research | Outperform |
| 2024-01-23 | 재확인 | Citigroup | Buy |
| 2024-01-17 | 재확인 | Piper Sandler | Overweight |
| 2024-01-17 | 재확인 | Wells Fargo | Overweight |
| 2024-01-09 | 개시 | BMO Capital Markets | Market Perform |
| 2023-12-20 | 재개 | Raymond James | Strong Buy |
| 2023-10-24 | 개시 | Seaport Research Partners | Buy |
| 2023-08-22 | 개시 | Wedbush | Outperform |
| 2023-08-01 | 재확인 | Argus | Buy |
| 2023-07-28 | 업그레이드 | China Renaissance | Hold → Buy |
| 2023-07-27 | 업그레이드 | HSBC Securities | Reduce → Hold |
| 2023-07-27 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-07-25 | 재확인 | Mizuho | Buy |
| 2023-07-25 | 업그레이드 | New Street | Neutral → Buy |
| 2023-07-19 | 재확인 | Jefferies | Buy |
| 2023-07-19 | 재확인 | Truist | Buy |
| 2023-07-17 | 재확인 | Credit Suisse | Outperform |
| 2023-07-17 | 재확인 | Goldman | Buy |
| 2023-07-17 | 재확인 | JMP Securities | Mkt Outperform |
| 2023-07-13 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-07-12 | 재확인 | Deutsche Bank | Buy |
| 2023-06-08 | 개시 | Wells Fargo | Equal Weight |
| 2023-05-15 | 업그레이드 | Loop Capital | Hold → Buy |
| 2023-04-27 | 재확인 | Credit Suisse | Outperform |
| 2023-04-27 | 재확인 | Deutsche Bank | Buy |
| 2023-04-27 | 재확인 | Evercore ISI | Outperform |
| 2023-04-27 | 재확인 | Goldman | Buy |
| 2023-04-27 | 재확인 | Guggenheim | Buy |
| 2023-04-27 | 재확인 | JMP Securities | Mkt Outperform |
| 2023-04-27 | 재확인 | JP Morgan | Overweight |
| 2023-04-27 | 재확인 | Mizuho | Buy |
| 2023-04-27 | 재확인 | Monness Crespi & Hardt | Buy |
| 2023-04-27 | 재확인 | Morgan Stanley | Overweight |
| 2023-04-27 | 재확인 | Oppenheimer | Outperform |
| 2023-04-27 | 재확인 | Piper Sandler | Overweight |
| 2023-04-27 | 재확인 | RBC Capital Mkts | Outperform |
| 2023-04-27 | 재확인 | Raymond James | Outperform |
| 2023-04-27 | 재확인 | Robert W. Baird | Outperform |
| 2023-04-27 | 재확인 | Rosenblatt | Buy |
| 2023-04-27 | 재확인 | Stifel | Buy |
| 2023-04-27 | 재확인 | TD Cowen | Market Perform |
| 2023-04-27 | 재확인 | Truist | Buy |
| 2023-04-27 | 재확인 | Wolfe Research | Outperform |
모두보기
메타 플랫폼스 주식(META)의 최신 뉴스
Meta’s Child Safety Trial Starts Today—Here’s What To Know - Forbes
Meta goes on trial in Oakland over alleged harms to children, with up to $1.4 trillion at stake - The Press Democrat
Opening statements in Meta's latest social media addiction trial beginABC News - ABC News - Breaking News, Latest News and Videos
US states take on Meta in pivotal trial over child social media addiction claims - The Guardian
Why states fought to present a united case against Meta over youth social media harms - Reuters
Meta Platforms Inc Stock (META) Moved Down by 3.56% on Aug 18: Facts Behind the Movement - TradingKey
VOTE: Do social media companies intentionally design their platforms to be addictive? - WSET
Meta Platforms stock down 27% YTD but poised fo... - Pluang
Opening statements set to begin in Meta's federal trial over child safety | National News | 2news.com - KTVN
Meta Platforms’ (META) Strong Growth Backdrop Highlights Valuation Disconnect - Yahoo Finance
How the Meta trial could change Facebook and Instagram forever - Euronews.com
Meta’s ‘Offense’ Isn’t Harm, It’s Happier And Healthier Young People - Forbes
Trial for 2023 lawsuit against social media giant Meta starts Tuesday - Denver7
Meta stock sinks as landmark social media addiction trial gets underway. What's at stake for the tech giant? - Fast Company
Opening statements for pivotal Meta federal case begin today - KING5.com
Opening arguments set to begin in Meta’s federal trial over child safety - AP News
Meta faces 29-state trial that could reshape Instagram and Facebook - Reuters
Alphabet vs. Meta Platforms: Which Is the Better AI Advertising Stock to Own for the Next 5 Years? - Yahoo Finance
Meta heads back to the courtroom to face its biggest social media addiction trial yet - Channel 3000
Meta Platforms, Inc. stock Analysis: Bearish Trend Amid $1.4T Legal Battle - The Cryptonomist
Meta Faces Landmark 29-State Trial Over Facebook and Instagram’s Impact on Young Users - Yahoo Finance
Meta faces pivotal kids’ safety trial - Politico
Meta lawsuits: Is social media facing a global legal reckoning? - Al Jazeera
Waddell & Associates LLC Grows Stake in Meta Platforms, Inc. $META - MarketBeat
Zevenbergen Capital Investments LLC Trims Stake in Meta Platforms, Inc. $META - MarketBeat
Tran Capital Management L.P. Lowers Stake in Meta Platforms, Inc. $META - MarketBeat
MBL Wealth LLC Trims Holdings in Meta Platforms, Inc. $META - MarketBeat
Atreides Management, LP's Meta Platforms Inc(META) Holding History - GuruFocus
Matrix Asset Advisors Inc. NY Boosts Stake in Meta Platforms, Inc. $META - MarketBeat
States Seek $200 Billion From Meta Over Child Social Media Addiction Claims - The New York Times
US states call for big changes to Instagram and Facebook as Meta child privacy trial begins - BBC
WealthBridge Investment Counsel Inc. Increases Stock Position in Meta Platforms, Inc. $META - MarketBeat
Meta trial over social media harm to children begins - DW.com
City National Bank of Florida MSD Acquires 1,246 Shares of Meta Platforms, Inc. $META - MarketBeat
Hartford Investment Management Co. Has $68.39 Million Stock Holdings in Meta Platforms, Inc. $META - MarketBeat
Major Meta trial begins as lawyers spar over witnesses, damages - The Express Tribune
AMI Investment Management Inc. Purchases 946 Shares of Meta Platforms, Inc. $META - MarketBeat
Meta Platforms, Inc. (NASDAQ:META) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
A look at major lawsuits against Meta and other social media companies over harms to kidsABC News - ABC News - Breaking News, Latest News and Videos
Meta to face massive social media addiction trial Tuesday - Yahoo Finance
Meta faces opening arguments in federal trial over child safety allegations - Seeking Alpha
Opening arguments set to begin in Meta's federal trial over child harms - WRAL
Meta faces mammoth fine in landmark social media trial - SiliconANGLE
Meta stares down trillion-dollar threat as landmark social media trial begins - japantimes.co.jp
Meta stock battered by threat that is hurting the social media giant - Yahoo Finance
Meta Faces 29 States in Court Tuesday. The Case Could Be Big Tech’s Big Tobacco Moment. - The Motley Fool
Meta faces potential penalty of up to US$1.4 trillion as landmark social media trial begins - The Business Times
UPDATE: Meta to face California and other states in landmark trial over social media harms - EdSource
Meta standing trial in Oakland for social media impacts on children - KRON4
Meta Stares Down Trillion-Dollar Threat as Landmark Social Media Trial Begins - Yahoo Finance
Meta Sees Trillion-Dollar Threat in Landmark Social Media Trial - Bloomberg Law News
메타 플랫폼스 (META) 재무 분석
매출
순이익
현금흐름
주당 순 이익
메타 플랫폼스 주식 (META) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Olivan Javier | Chief Operating Officer |
Aug 10 '26 |
Sale |
602.70 |
434 |
261,573 |
5,856 |
6.52%
0.30%
자본화:
|
볼륨(24시간):